Neolitics is proud to announce that we have entered our first independent third party pilot with SPC Technologies. SPC Technologies is led by Duquesne University School of Pharmaceutical Sciences Professors Carl Anderson and James Drennen. SPC Technologies will leverage almost four decades of analytical instrumentation, data analysis, pharmaceutical sciences, and regulatory documentation experience in the execution of Neolitics’ 1st pre-commercial pilot.  Their team is at the forefront of pharmaceutical process automation and we believe strongly that they will play a key role in Neolitics’ success within this sector.